BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 27828674)

  • 1. Development, health, and international policy: the research and innovation dimension.
    Buss PM; Chamas C; Faid M; Morel C
    Cad Saude Publica; 2016 Nov; 32Suppl 2(Suppl 2):e00046815. PubMed ID: 27828674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health and innovation: economic dynamics and Welfare State in Brazil.
    Gadelha CA; Braga PS
    Cad Saude Publica; 2016 Nov; 32Suppl 2(Suppl 2):e00150115. PubMed ID: 27828678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EFFECTIVE INDICATORS FOR SCIENCE INTERNATIONALIZATION.
    Cunha-Melo JR
    Rev Col Bras Cir; 2015; 42 Suppl 1():20-5. PubMed ID: 27437961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smoking control: challenges and achievements.
    Silva LC; Araújo AJ; Queiroz ÂM; Sales MD; Castellano MV;
    J Bras Pneumol; 2016; 42(4):290-298. PubMed ID: 27832238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The experience of women infected by the COVID-19 during pregnancy in Brazil: a qualitative study protocol.
    Freitas-Jesus JV; Rodrigues L; Surita FG
    Reprod Health; 2020 Jul; 17(1):108. PubMed ID: 32641133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innovation in healthcare services: notes on the limits of field research.
    Costa LS
    Cad Saude Publica; 2016 Nov; 32Suppl 2(Suppl 2):e00151915. PubMed ID: 27828679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Access to and use of high blood pressure medications in Brazil.
    Mengue SS; Bertoldi AD; Ramos LR; Farias MR; Oliveira MA; Tavares NU; Arrais PS; Luiza VL; Pizzol TD
    Rev Saude Publica; 2016 Dec; 50(suppl 2):8s. PubMed ID: 27982380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Geographic accessibility to cancer treatment in Brazil: A network analysis.
    Fonseca BP; Albuquerque PC; Saldanha RF; Zicker F
    Lancet Reg Health Am; 2022 Mar; 7():100153. PubMed ID: 36777653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation in health: participatory methodology and involvement of municipal managers.
    Almeida CA; Tanaka OY
    Rev Saude Publica; 2016 Aug; 50():45. PubMed ID: 27509011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Building inclusive health innovation systems: lessons from India.
    Abrol D; Sundararaman T; Madhavan H; Joseph KJ
    Cad Saude Publica; 2016 Nov; 32Suppl 2(Suppl 2):e00045215. PubMed ID: 27828673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health, development and innovation: a contribution of the critical theory of technology to the discussion.
    Souza LE
    Cad Saude Publica; 2016 Nov; 32Suppl 2(Suppl 2):e00029615. PubMed ID: 27828671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PNAUM: integrated approach to Pharmaceutical Services, Science, Technology and Innovation.
    Gadelha CA; Costa KS; Nascimento JM; Soeiro OM; Mengue SS; Motta ML; Carvalho AC
    Rev Saude Publica; 2016 Dec; 50(suppl 2):3s. PubMed ID: 27982379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investments and costs of oral health care for Family Health Care.
    Macêdo MS; Chaves SC; Fernandes AL
    Rev Saude Publica; 2016 Jul; 50():. PubMed ID: 27463254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health technology assessment (HTA) organizations: dimensions of the institutional and political framework.
    Novaes HM; Soárez PC
    Cad Saude Publica; 2016 Nov; 32Suppl 2(Suppl 2):e00022315. PubMed ID: 27828669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of Oswaldo Paulo Forattini to public health: analysis of scientific production.
    Reis JG; Kobayashi KM; Ueno HM; Ribeiro CM; Cardoso TA
    Rev Saude Publica; 2016 Dec; 50():73. PubMed ID: 28099651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment in the primary care of the State of São Paulo, Brazil: incipient actions in sexual and reproductive health.
    Nasser MA; Nemes MIB; Andrade MC; Prado RRD; Castanheira ERL
    Rev Saude Publica; 2017 Aug; 51():77. PubMed ID: 28832755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development policy for the Brazilian health industry and qualification of national public laboratories.
    Viana AL; Silva HP; Ibañez N; Iozzi FL
    Cad Saude Publica; 2016 Nov; 32Suppl 2(Suppl 2):e00188814. PubMed ID: 27828684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SOCIAL INCLUSION AND SOLIDARITY IN STRICT POST-GRADUATION: EXPERIENCING THE LABORATORY "SCIENTIFIC WAKE FOR THE FUTURE" (PRIMARY AND SECONDARY EDUCATION).
    Noronha SA; Bernardes L; Noronha SM; Nascimento FA; Ferreira LM
    Rev Col Bras Cir; 2015; 42 Suppl 1():44-7. PubMed ID: 27437968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telemedicine: challenges to dissemination in Brazil.
    Maldonado JM; Marques AB; Cruz A
    Cad Saude Publica; 2016 Nov; 32Suppl 2(Suppl 2):e00155615. PubMed ID: 27828681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Healthcare systems, the State, and innovation in the pharmaceutical industry.
    Delgado IJ
    Cad Saude Publica; 2016 Nov; 32Suppl 2(Suppl 2):e00037415. PubMed ID: 27828672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.